Digital Therapeutics for Disease Management

DTx for Healthcare

Digital therapeutics (DTx) is a rapidly growing field in the healthcare industry, providing new and innovative ways to treat and manage diseases and disorders. With the rise of telemedicine and remote patient monitoring, DTx offer the potential to improve patient outcomes, increase patient engagement, and reduce healthcare costs. At Innovenn, we began working digital health space in 2014 and have grown as experts in the development of digital health solutions which can also be characterized as Software as A Medical Device (SaMD). Our team can assist with the design, development, validation, and logistical planning for the launch of DTx and other SaMD products. This is an exciting field which promises to accelerate health advancements which has FDA prompting to launch the Digital Health Center of Excellence. The Digital Health Center of excellence was established to empower stakeholders to advance health care by fostering responsible and high-quality digital health innovation.

DTx 101

DTx deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders. This includes a wide range of products such as mobile apps, digital programs, and remote patient monitoring devices that may be used alone or in conjunction with other therapies to improve patient outcomes, increase patient engagement, and reduce healthcare costs.

One of the key advantages of DTx is the ability to deliver targeted and personalized treatment to patients. Real-time tracking of symptoms and medication adherence can be made possible through a DTx app, making it easier for healthcare providers to monitor and adjust treatment plans as needed. Additionally, DTx can provide patients with educational and self-management feedback resources, empowering them to better understand and manage their condition.

DTx not only enhance patient outcomes, but also offer opportunities to lower healthcare expenses. A study by the Journal of Medical Internet Research found that DTx can lead to a reduction in healthcare costs and an improvement in patient outcomes for conditions such as diabetes, hypertension, and heart failure¹. The use of DTx can also reduce the need for in-person visits to healthcare providers, making healthcare more accessible to patients in remote or underserved areas.

What are the regulatory considerations when developing DTx?

DTx products are held to the same standards of evidence and regulatory oversight as traditional medical treatments. The claims made by the developer (or manufacturer) must be approved by a regulatory or market authorization body unless the product is considered under enforcement discretion.

Evidence is needed to validate the accuracy and reproducibility of data collection, data driven interventions, and clinical mechanisms of action. Software as a medical device products must also adhere to current International and U.S. regulations including but not limited to ISO 13485, and 21 CFR 820).

In addition, DTx benefit from early user input and a rigorous validation program to validate the safety and efficacy of the DTx across potential use scenarios and with various users ensuring the highest possible usability as demonstrated through the conduct of Human Factors Testing.

Further, due to the sensitive nature of personal health information (PHI) which may be collected or shared via the DTx, patient privacy and data security considerations to enable protection of the patient’s data are vital. Design inputs and development considerations must consider methods for adherence to Privacy and Security guidances and regulations such as Health Insurance Portability and Accountability Act (HIPPA) and General Data Production Regulation (DGPF).

At Innovenn, we believe that designing in usability, privacy, security, scalability, data hosting, governance, ongoing risk analyses and mitigation efforts from the very early stages of design input through the complete product lifecycle are paramount.

FAQs

What is the difference between DTx and traditional medications?

DTx refers to the use of software and technology to prevent, manage, and treat diseases and disorders. They may add to an existing treatment plan that could include traditional medications (prescription drugs and over-the-counter medications), devices, or provide standalone intervention.

How do DTx help with disease management?

DTx can provide targeted and personalized treatment to patients, improve patient outcomes, increase patient engagement, and reduce healthcare costs. Some examples of DTx currently on the market include mobile apps for diabetes management, digital programs for mental health treatment, and remote monitoring devices for heart failure management.

What are some of the challenges with implementing DTx?

Some of the challenges with implementing DTx include ensuring regulatory compliance, data privacy and security, and ensuring that the technology is user-friendly and easy for patients to use. The most important considerations for implementing health technologies are the need to carefully define the problem requiring a solution, understand the unmet needs of the population, and to design a solution that will make a difference in the patients’ lives and will encourage patient engagement.

Why Choose Innovenn for Digital Therapeutics (DTx) for Disease Management?

Choosing Innovenn for your DTx needs provides access to a depth of experience in design controls, software development, Human Factors Engineering, user experience, regulatory, privacy, and security who can support the development of health changing solutions. With an understanding of the importance of getting products to market as efficiently as possible, Innovenn always keeps patient needs in the center of development decisions.

To learn more about Innovenn’s Digital Therapeutics (DTx) for Disease Management services, contact us to discuss your specific needs.

Contact an Expert

DTx for Healthcare

DTx 101

What are the regulatory considerations when developing DTx?

FAQs

Why Choose Innovenn for Digital Therapeutics (DTx) for Disease Management?

Reference

Where healthcare innovation intersects with improved patient outcomes

Contact Innovenn